BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 32359513)

  • 1. Octreotide improves human lymphatic fluid transport a translational trial.
    Holm-Weber T; Skov F; Mohanakumar S; Thorup L; Riis T; Christensen MB; Sonne DP; Jensen PB; Bødtkjer DB; Hjortdal VE
    Eur J Cardiothorac Surg; 2024 Jan; 65(1):. PubMed ID: 37951584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of PepT1 (SLC15A1) Substrate Characteristics of Therapeutic Cyclic Peptides.
    Bajraktari-Sylejmani G; von Linde T; Burhenne J; Haefeli WE; Sauter M; Weiss J
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic solid-phase extraction of high molecular weight peptides using stearic acid-functionalized magnetic hydroxyapatite nanocomposite: determination of some hypothalamic agents in biological samples.
    Salehpour N; Bayatloo MR; Nojavan S
    Anal Bioanal Chem; 2021 Dec; 413(30):7609-7623. PubMed ID: 34668043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact plasma quantification of the large therapeutic lipopeptide bulevirtide.
    Sauter M; Blank A; Stoll F; Lutz N; Haefeli WE; Burhenne J
    Anal Bioanal Chem; 2021 Sep; 413(22):5645-5654. PubMed ID: 34018034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of triple quadrupole tandem mass spectrometry to the bioanalysis of collision-induced dissociation-resistant cyclic peptides - Ultra-sensitive quantification of the somatostatin-analog pasireotide utilizing UHPLC-MS/MS.
    Sauter M; Uhl P; Burhenne J; Haefeli WE
    J Pharm Biomed Anal; 2021 Feb; 194():113728. PubMed ID: 33234413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS.
    Sauter M; Uhl P; Burhenne J; Haefeli WE
    J Pharm Anal; 2020 Jun; 10(3):233-239. PubMed ID: 32612869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy to improve the quantitative LC-MS analysis of molecular ions resistant to gas-phase collision induced dissociation: application to disulfide-rich cyclic peptides.
    Ciccimaro E; Ranasinghe A; D'Arienzo C; Xu C; Onorato J; Drexler DM; Josephs JL; Poss M; Olah T
    Anal Chem; 2014 Dec; 86(23):11523-7. PubMed ID: 25371986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics.
    Sauter M; Uhl P; Burhenne J; Haefeli WE
    J Pharm Biomed Anal; 2020 Jul; 186():113276. PubMed ID: 32353679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of disulfide bond position in proteins and sequence analysis of cystine-bridged peptides by tandem mass spectrometry.
    Bean MF; Carr SA
    Anal Biochem; 1992 Mar; 201(2):216-26. PubMed ID: 1632509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-extraction disulfide bond cleavage for MS/MS quantification of collision-induced dissociation-resistant cystine-cyclized peptides and its application to the ultra-sensitive UPLC-MS/MS bioanalysis of octreotide in plasma.
    Sauter M; Uhl P; Burhenne J; Haefeli WE
    Anal Chim Acta; 2020 Jun; 1114():42-49. PubMed ID: 32359513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein disulfide bond determination by mass spectrometry.
    Gorman JJ; Wallis TP; Pitt JJ
    Mass Spectrom Rev; 2002; 21(3):183-216. PubMed ID: 12476442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel synthetic approach of tryptophan-containing cystine peptides by regioselective disulfide bond-forming reaction using the silyl chloride-sulfoxide system].
    Fujiwara Y
    Yakugaku Zasshi; 2000 Feb; 120(2):197-205. PubMed ID: 10689966
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.